JPS606647A - アルフアメニン及びその関連化合物と合成法 - Google Patents

アルフアメニン及びその関連化合物と合成法

Info

Publication number
JPS606647A
JPS606647A JP58107888A JP10788883A JPS606647A JP S606647 A JPS606647 A JP S606647A JP 58107888 A JP58107888 A JP 58107888A JP 10788883 A JP10788883 A JP 10788883A JP S606647 A JPS606647 A JP S606647A
Authority
JP
Japan
Prior art keywords
group
formula
amino acid
page
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58107888A
Other languages
English (en)
Japanese (ja)
Inventor
Hamao Umezawa
梅沢　浜夫
Takaaki Aoyanagi
青柳　高明
Kuniaki Tatsuta
邦明 竜田
Takeshi Nakamura
健 中村
Shunzo Fukatsu
深津　俊三
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Priority to JP58107888A priority Critical patent/JPS606647A/ja
Priority to EP84106562A priority patent/EP0129163B1/en
Priority to DE8484106562T priority patent/DE3466213D1/de
Priority to AT84106562T priority patent/ATE29713T1/de
Priority to DK295584A priority patent/DK295584A/da
Priority to ZA844530A priority patent/ZA844530B/xx
Priority to GR75033A priority patent/GR82161B/el
Publication of JPS606647A publication Critical patent/JPS606647A/ja
Priority to US07/079,319 priority patent/US4870207A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
JP58107888A 1983-06-17 1983-06-17 アルフアメニン及びその関連化合物と合成法 Pending JPS606647A (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP58107888A JPS606647A (ja) 1983-06-17 1983-06-17 アルフアメニン及びその関連化合物と合成法
EP84106562A EP0129163B1 (en) 1983-06-17 1984-06-08 Arphamenine and its related compounds, a process for their preparation and their use as medicaments
DE8484106562T DE3466213D1 (en) 1983-06-17 1984-06-08 Arphamenine and its related compounds, a process for their preparation and their use as medicaments
AT84106562T ATE29713T1 (de) 1983-06-17 1984-06-08 Arphamenin und ihm verwandte verbindungen, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DK295584A DK295584A (da) 1983-06-17 1984-06-15 Arphamenin samt beslaegtede forbindelser, fremgangsmaade til fremstilling deraf og deres anvendelse som laegemidler
ZA844530A ZA844530B (en) 1983-06-17 1984-06-15 Arphamenine and its related compounds,a process for their preparation and their use as medicaments
GR75033A GR82161B (enExample) 1983-06-17 1984-06-15
US07/079,319 US4870207A (en) 1983-06-17 1987-07-30 Synthesis of arphamenine A

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58107888A JPS606647A (ja) 1983-06-17 1983-06-17 アルフアメニン及びその関連化合物と合成法

Publications (1)

Publication Number Publication Date
JPS606647A true JPS606647A (ja) 1985-01-14

Family

ID=14470614

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58107888A Pending JPS606647A (ja) 1983-06-17 1983-06-17 アルフアメニン及びその関連化合物と合成法

Country Status (8)

Country Link
US (1) US4870207A (enExample)
EP (1) EP0129163B1 (enExample)
JP (1) JPS606647A (enExample)
AT (1) ATE29713T1 (enExample)
DE (1) DE3466213D1 (enExample)
DK (1) DK295584A (enExample)
GR (1) GR82161B (enExample)
ZA (1) ZA844530B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2669510B2 (ja) * 1990-06-15 1997-10-29 ナショナル・リサーチ・カウンシル・オブ カナダ ヒルジンのアミノ酸配列に基づくトロンビン阻害剤

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086069A (en) * 1990-02-05 1992-02-04 Rorer Pharmaceutical Corporation Anti-thrombotic peptide and pseudopeptide derivatives
US6060451A (en) * 1990-06-15 2000-05-09 The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin
WO1992018117A1 (en) * 1991-04-11 1992-10-29 Rhone-Poulenc Rorer International (Holdings), Inc. Anti-thrombotic peptide and pseudopeptide derivatives
US5364961A (en) * 1992-06-15 1994-11-15 Monsanto Company Process for making optically active α-amino ketones

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843696A (en) * 1972-09-05 1974-10-22 Syva Co Methadone analog compounds
GB2090595B (en) * 1978-11-25 1983-05-11 Nippon Kayaku Kk Threo-3-amino-2-hydroxybutanoylacetice acid derivatives
JPS58212791A (ja) * 1982-06-07 1983-12-10 Microbial Chem Res Found 新生理活性物質アルフアメニン及びその製造法
JPS59144717A (ja) * 1983-02-07 1984-08-18 Microbial Chem Res Found 鎮痛剤
JPS60166657A (ja) * 1984-02-10 1985-08-29 Nitto Boseki Co Ltd アルギニル−３−カルボキシ−４−ヒドロキシアニリド

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2669510B2 (ja) * 1990-06-15 1997-10-29 ナショナル・リサーチ・カウンシル・オブ カナダ ヒルジンのアミノ酸配列に基づくトロンビン阻害剤

Also Published As

Publication number Publication date
ZA844530B (en) 1985-01-30
US4870207A (en) 1989-09-26
EP0129163A1 (en) 1984-12-27
ATE29713T1 (de) 1987-10-15
GR82161B (enExample) 1984-12-13
DK295584D0 (da) 1984-06-15
DE3466213D1 (en) 1987-10-22
DK295584A (da) 1984-12-18
EP0129163B1 (en) 1987-09-16

Similar Documents

Publication Publication Date Title
EP0236872B1 (de) Hydroxylaminderivate, deren Herstellung und Verwendung für Heilmittel
DE3687103T2 (de) Verfahren zur herstellung von n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline.
DD201787A5 (de) Verfahren zur herstellung von substituierten acylderivaten von 1,2,3,4-tetrahydroisochinolin-3-carbonsaeuren
JPS6193194A (ja) 高強度甘味剤として有用なα−Ｌ−アスパルチル−Ｄ−フエニルグリシンエステルおよびアミド
DE3236725A1 (de) N-(4-(3-aminopropyl)-aminobutyl)-2-(w-guanidino-fettsaeure-amido)-2-substituierte ethanamide, ihre salze und verfahren zu ihrer herstellung
EP0127411A2 (en) Method of preparing alpha-l-aspartyl-l-phenylalanine methyl ester and its hydrochloride
US4908353A (en) Novel dipeptide useful as a plant growth regulator
DE60209458T2 (de) Verfahren zur Synthese von (2S,3aS,7aS)-1-(S)-Alanyl-octahydro-1H-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril
Sheehan et al. Amino group protection in peptide synthesis. 4, 5-Diphenyl-4-oxazolin-2-one group
DE60220877T2 (de) Verfahren zur Herstellung von hochreinem Perindopril und Zwischenverbindungen nützlich in der Synthese
EP0052870A1 (de) Aminosäurederivate und Verfahren zu ihrer Herstellung
DE60128554T2 (de) Verfahren zur herstellung von estern des n-ä(s)-1-carboxybutylü-(s)-alanins und ihre verwendung in der synthese von perindopril
EP0818463B1 (en) Aspartyl dipeptide amide derivatives and sweeteners
CA1151154A (en) Tripeptide amides and process for preparing same
DE69911061T2 (de) N-3, 3-dimethylbutyl-l-asparaginsäure und ihre ester, verfahren zur herstellung dieser und das verfahren um daraus n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanin-1-methylester herzustellen
DE60111364T2 (de) Verfahren zur Herstellung von N-[(S)-1-Carboxybutyl]-(S)-Alanine-Estern und Verwendung zur Synthese von Perindopril
EP0394194A1 (de) Geschützte Aminosäuren und Verfahren zu ihrer Herstellung
DE3217547A1 (de) Krebshemmende verbindungen und verfahren zu ihrer synthese
US4870207A (en) Synthesis of arphamenine A
DE2431963A1 (de) Verfahren zur herstellung heterocyclischer verbindungen
DE2944086A1 (de) Peptidderivate
DE60213880T2 (de) Verfahren zur herstellung von lisinopril
FI83656B (fi) Nya tyroninderivat.
US4806641A (en) Salts of 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazine and amino compounds
JPS61106569A (ja) Ｌ−アスパルチル−ｄ−アミノ酸ジペプチドの枝鎖アミド類の中間体